| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 04/20/1993 | US5204108 Microspheres |
| 04/20/1993 | US5204107 Bound to deacetylated chitin; side effect reduction; sustained release over several months |
| 04/20/1993 | US5204103 Using vegetable fiber from Plantago ovata with holder for applying to skin; ulcers |
| 04/20/1993 | US5204101 Synergistic mixture of dried powders of sheep sorrel, pokeweed and lemon; dramatic rise in lymphocyte count |
| 04/20/1993 | US5204096 Pre-S gene coded peptide hepatitis B immunogens, vaccines, diagnostics, and synthetic lipid vesicle carriers |
| 04/20/1993 | US5204090 Waterproof high-SPF sunscreen compositions |
| 04/20/1993 | US5204087 Composition for foaming preparation |
| 04/20/1993 | US5203768 Transdermal delivery device |
| 04/20/1993 | CA1316458C Pharmaceutical composition for piperidinoalkanol derivatives |
| 04/16/1993 | CA2080574A1 Slow release syneresing polymeric drug delivery device |
| 04/16/1993 | CA2079830A1 Polymeric compositions useful as controlled release implants |
| 04/15/1993 | WO1993007492A1 Preparation of prothrombin time reagents from recombinant human tissue factor and purified natural and synthetic phospholipids |
| 04/15/1993 | WO1993006921A1 Particles, method of preparing said particles and uses thereof |
| 04/15/1993 | WO1993006881A1 Therapeutic agent in hydrophilic matrix |
| 04/15/1993 | WO1993006854A1 Pharmaceutical compositions comprising a calcitonin, a glycyrrhizinate as absorption enhancer and benzyl |
| 04/15/1993 | WO1993006824A1 Preparations containing transition-metal compounds for anti-tumour therapy and/or stimulating the haematopoietic system |
| 04/15/1993 | WO1993006822A1 Trimethoprim oral liquid |
| 04/15/1993 | WO1993006821A1 Sustained-release tablet |
| 04/15/1993 | WO1993006820A1 Holder and packaging for a hardened medicated matrix |
| 04/15/1993 | WO1993006819A1 Osmotic drug delivery devices with hydrophobic wall materials |
| 04/15/1993 | WO1993006813A2 Hair treatment composition |
| 04/15/1993 | WO1993006812A2 Use of an emulsion to prepare an intravenously administered medicament for treating skin diseases |
| 04/15/1993 | WO1993006803A1 Device for administering drug transdermally with a controlled temporal change in skin flux |
| 04/15/1993 | DE4204222C1 Pad for alleviating cold symptoms and respiratory infections - comprises bonded fabric support and bonded fabric layer with membrane function which releases vapour of essential oils |
| 04/15/1993 | DE4134158A1 Verwendung von wasser- oder lipidloeslichen uebergangsmetallverbindungen pharmazeutische zubereitungen und verfahren zur herstellung pharmazeutischer zubereitungen fuer die antitumortherapie und/oder stimulierung des haematopoetischen systems Use of water or lipidloeslichen by transition metal compounds pharmaceutical preparations and process for manufacture of pharmaceutical preparations for the antitumor therapy and / or stimulation of the hematopoietic system |
| 04/15/1993 | DE4133694A1 Verwendung einer emulsion, zur herstellung eines arzneimittels zur iv-verabreichung zur behandlung von hauterkrankungen Use of an emulsion, for the manufacture of a medicament for intravenous administration for the treatment of skin diseases |
| 04/15/1993 | CA2120755A1 Pharmaceutical compositions comprising a calcitonin, a glycyrrhizinate as absorption enhancer and benzyl |
| 04/15/1993 | CA2120508A1 Device for administering drug transdermally with a controlled temporal change in skin flux |
| 04/15/1993 | CA2120497A1 Therapeutic agent in hydrophilic matrix |
| 04/15/1993 | CA2116326A1 Holder and packaging for a hardened medicated matrix |
| 04/14/1993 | EP0537092A1 Infracellular vesicular vectors and their application in cosmetic and medical compositions and culture media |
| 04/14/1993 | EP0537070A1 Compositions containing compound TMK688 and its analogs |
| 04/14/1993 | EP0537000A2 Poly(orthocarbonate acetal) bioerodible polymers |
| 04/14/1993 | EP0536595A1 Process for coating pharmaceutical preparations |
| 04/14/1993 | EP0536360A1 Topical treatment of acne |
| 04/14/1993 | EP0536297A1 Process and apparatus for removal of dna and viruses |
| 04/14/1993 | EP0536294A1 Starch encapsulation of biologically active agents by a continuous process |
| 04/14/1993 | EP0536277A1 Amantadine hydrochloride suspension with enhanced dissolution characteristics for use in soft gelatin capsules |
| 04/14/1993 | EP0536255A1 Ophthalmic suspensions. |
| 04/14/1993 | EP0536250A1 Aerosol drug formulations |
| 04/14/1993 | EP0536245A1 Novel, protracted insulin analogues |
| 04/14/1993 | EP0536235A1 Pressurised aerosol compositions. |
| 04/14/1993 | EP0536179A1 Bioceramic system for delivery of bioactive compounds |
| 04/14/1993 | EP0505474A4 Antiperspirant |
| 04/14/1993 | EP0446268B1 Use of acetyl d-carnitine in the therapeutic treatment of glaucoma |
| 04/14/1993 | EP0437478B1 Cyclodextrin-peptide complexes |
| 04/14/1993 | EP0349644B1 A method for the preparation of coated solid medicament form |
| 04/14/1993 | CN1070826A Made method of spleen and stomach health plaster |
| 04/14/1993 | CN1020253C Pasteurization for immunoglobulin solution |
| 04/14/1993 | CN1020252C Prepn. of rifampin eye ointment |
| 04/13/1993 | USRE34222 Treating magnesium/potassium deficiency by administering controlled release formulation |
| 04/13/1993 | US5202431 Partial esters of hyaluronic acid |
| 04/13/1993 | US5202352 Antitumor agents |
| 04/13/1993 | US5202313 Bilobalide derivatives, their applications and formulations containing them |
| 04/13/1993 | US5202311 Fibroblast growth factor stabilized with salt of sucrose octasulfate |
| 04/13/1993 | US5202159 Preparation method of microdispersed tablet formulation of spray-dried sodium diclofenac enteric-coated microcapsules |
| 04/13/1993 | US5202129 Process for micronizing slightly-soluble drug |
| 04/13/1993 | US5202128 Sustained release pharmaceutical composition |
| 04/13/1993 | US5202126 Protein synthesis promoter |
| 04/13/1993 | US5202125 Method and systems for administering nitroglycerin transdermally at enhanced transdermal fluxes |
| 04/13/1993 | US5202110 Formulations for delivery of beclomethasone diproprionate by metered dose inhalers containing no chlorofluorocarbon propellants |
| 04/13/1993 | US5201728 Subcutaneous implantable multiple-agent delivery system |
| 04/13/1993 | US5201326 Tampon for medical or hygienic purposes and method of making the same |
| 04/13/1993 | CA1316110C Sustained release matrix formulations |
| 04/13/1993 | CA1316109C Sustained release drug preparation |
| 04/13/1993 | CA1316108C Formulation for preparing sustained release drugs for oral administration |
| 04/13/1993 | CA1316107C Granular agent for ruminant and production method thereof |
| 04/13/1993 | CA1316106C Skin permeation enhancer compositions using glycerol monolaurate |
| 04/13/1993 | CA1316062C Active substance-containing plaster for the controlled administration of active substances to the skin, the use thereof and a process for the controlled administration of active substances to the skin |
| 04/12/1993 | WO1993006862A1 Antibody composition |
| 04/12/1993 | CA2097932A1 Antibody containing composition |
| 04/12/1993 | CA2079988A1 Poly(orthocarbonate acetal) bioerodible polymers |
| 04/10/1993 | CA2077827A1 Stable sf1228 water in oil emulsions |
| 04/09/1993 | CA2079938A1 Solid formulation containing amide derivative and method of manufacturing the formulation |
| 04/08/1993 | DE4203285A1 Pharmaceutical prepn. contg. combination of aspirin and nocloprost - useful as analgesic, antipyretic and antirheumatic compsn. without damage to gastrointestinal tract |
| 04/08/1993 | DE4132176A1 Treibmittel fuer aerosole und dosieraerosole Propellants for aerosols and MDIs |
| 04/08/1993 | CA2079860A1 Coating of drug forms |
| 04/07/1993 | EP0536087A1 System-container for the prolonged diffusion of an active component |
| 04/07/1993 | EP0535937A1 Prolonged release microparticle preparation and production of the same |
| 04/07/1993 | EP0535899A1 Injectable extended release formulations and methods |
| 04/07/1993 | EP0535841A1 Use of a combination of iburofen and codeine for the treatment of pain |
| 04/07/1993 | EP0535827A1 Calcitonin suspensions for oral administration |
| 04/07/1993 | EP0535734A1 Long acting injectable formulations containing hydrogenated castor oil |
| 04/07/1993 | EP0535704A1 Glycyrrhizin suppository |
| 04/07/1993 | EP0535567A1 Liposomes containing volatile inhalation anaesthetics, their preparation and their use |
| 04/07/1993 | EP0535545A1 Artificial tears containing oil and wax |
| 04/07/1993 | EP0535534A1 Biocompatible emulsion particles |
| 04/07/1993 | EP0535530A1 Extended-life drug filled patch |
| 04/07/1993 | EP0535327A1 Pharmaceutical composition containing felbinac |
| 04/07/1993 | EP0535317A1 Drug for the treatment of agitation state and nerve dysfonction |
| 04/07/1993 | EP0535269A1 Pharmaceutical compositions containing thiazolidinedione derivatives |
| 04/07/1993 | EP0535237A1 Composition for relieving skin irritation and external preparation for percutaneous adminstration containing the same |
| 04/07/1993 | EP0535200A1 Procedure for the purification of hyaluronic acid and fraction of pure hyaluronic acid for ophthalmic use |
| 04/07/1993 | EP0535178A1 Halohydrocarbon-free timed-release coating solution for pharmaceutical preparations |
| 04/07/1993 | EP0535111A1 Transdermal administration of buprenorphine |
| 04/07/1993 | EP0535001A1 Composite molecular system for the contra-escalatory treatment of viral infections. |
| 04/07/1993 | CN1070567A Magnetic treatment tablet with medicine |
| 04/06/1993 | US5200453 Preservative for ophthalmic solutions |
| 04/06/1993 | US5200430 Debridement of bodily cavities using debridement fluids |
| 04/06/1993 | US5200393 A lipid excipient of mono-oleoyl phosphatidylethanolamine (a lysophospholipid), a salt solution and a water soluble protein e.g. insulin |